XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
  UK
  USA
  World
  India
   Madhya Pradesh
   Medical Tourism
  South Africa
  New Zealand
  Australia
  Canada Healthcare
  China Healthcare
  Africa
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Aug 19th, 2006 - 22:18:38

India Channel
subscribe to India newsletter

Medical News : Healthcare : India

   DISCUSS   |   EMAIL   |   PRINT
India's Biocon to hike investment in Scotland
Feb 7, 2006, 15:19, Reviewed by: Dr. Priya Saxena

"There is a lot of pre-clinical toxicology that needs to be done. India has some gaps that Scotland could fill very easily."

 
Indian biotechnology major Biocon will increase investment in Scotland which is an emerging destination for clinical development of drugs.

Bangalore-based Biocon has had close relationship with life sciences organisations in Scotland. There are more than 550 life sciences organisations in Scotland, employing more than 26,500 people, according to Scottish Enterprise.

Speaking to Financial Times during a visit to Scotland, Kiran Mazumdar-Shaw, chairman and managing director of Biocon, said: "Last year we spent $2 million in this area and in future years that will grow to tens of millions of dollars - work that I think I could very easily shift here.

"There is a lot of pre-clinical toxicology that needs to be done. India has some gaps that Scotland could fill very easily."

The financial newspaper reported that although India enjoyed a considerable cost advantage, Mazumdar-Shaw explained that some products needed global trials.

"You can easily do development work outside the US as long as you conform with FDA (Food and Drug Administration) standards," she said.

During her visit, she attended her first meeting of the international advisory board of Scottish Enterprise.

The board is part of the government-funded development body's "globalscot" network, a group of 900 senior business leaders based overseas who try to help Scottish companies and the economy.

The Financial Times report said that Mazumdar-Shaw was introduced to the network by John Shaw, her Scottish husband. She said it had been "an eye-opener" for her to discover the strength of Scotland's skills base, which meant work could be done more quickly than in the US.

The report added that Mazumdar-Shaw was also excited by Scotland's potential as a base for epidemiological studies because of the links between government, universities and life sciences companies.

Epidemiological studies relate diseases and their causes by studying large populations.
 

- Indo-Asian News Service
 

 
Subscribe to India Newsletter
E-mail Address:

 



Related India News

Indian scientists develop Elisa tests for avian influenza
Delhi reports 222 cholera cases in four months
Over 200,000 miners in Rajasthan suffer from silicosis
Doctors join hands to spread message of safe motherhood
Hindustan Latex launches first female condom
Chhattisgarh to become eco-tourism hub
Obesity cure lures foreigners to India
Change behaviour to combat AIDS
India to introduce rating system for hospitals
Japanese trust to train leprosy cured people in India


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us